Showing results (51-60 of 301) with videos related to
Sort By:
Pageof 31
Chemico-Biological Interactions|December 1, 1984
Heterogeneity of hepatic microsomal UDP-glucuronosyltransferase(s) activities: comparison between human and mammalian species activitiesJ A Boutin, B Antoine, A M Batt, et al.Analytical Biochemistry|October 1, 1990
Assay of tyrosine protein kinase activity from HL-60 by high-performance liquid chromatography for specificity studiesG Ferry, A P Ernould, A Genton, et al.Genes|January 23, 2024
Polymorphisms and Pharmacogenomics of NQO2: The Past and the FutureElzbieta Janda, Jean A Boutin, Carlo De Lorenzo, et al.Medecine Sciences : M/S|September 13, 2016
[Cryo-microscopy, an alternative to the X-ray crystallography?]Jean A Boutin, Zhuolun Li, Laurent Vuillard, et al.Mini Reviews in Medicinal Chemistry|March 23, 2004
The emergence of selective 5-HT 2B antagonists structures, activities and potential therapeutic applicationsG Poissonnet, J G Parmentier, J A Boutin, et al.Pharmacological Research Communications|March 1, 1984
Inhibition studies of microsomal UDP-glucuronosyltransferase activities by furosemide and salicylamideJ A Boutin, J Thomassin, G Siest, et al.Biochemical and Biophysical Research Communications|May 15, 1989
Partial purification and characterization of a new p36/40 tyrosine protein kinase from HL-60J A Boutin, A P Ernould, A Genton, et al.The Journal of Chemical Physics|May 10, 2013
Metal-organic frameworks with wine-rack motif: what determines their flexibility and elastic properties?Aurélie U Ortiz, A Boutin, Alain H Fuchs, et al.Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1991
[Farnesyltransferase as target for non-cytotoxic anti-cancer agents: first steps]J P Tassin, J A Boutin, A P Ernould, et al.Journal of Pineal Research|March 10, 2010
Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligandLudwig Vincent, William Cohen, Philippe Delagrange, et al.Pageof 31